Efficacy of combined docetaxel and bevacizumab treatment in hormone-refractory metastatic prostate cancer pretreated with docetaxel: A single institution experience

Authors
Category Primary study
JournalJournal of Clinical Oncology
Year 2010
This article has no abstract
Epistemonikos ID: dcde25150029de3e7170e93bdeffd7e4bb8558a2
First added on: Mar 01, 2025